{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:08:52Z","timestamp":1787584132351,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mutations in the neuronal sodium voltage-gated channel, alpha subunit 1 (<jats:italic>SCN1A)<\/jats:italic> gene have been associated with epilepsy. We investigated the <jats:italic>SCN1A-A3184G<\/jats:italic> polymorphism among Egyptian children and adolescents with non-lesional epilepsy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective case \u2013 control observational study was done in Mansoura University Children\u2019s Hospital, Egypt including 326 children with non-lesional epilepsy (163 antiepileptic drugs (AEDs) resistant cases &amp; 163 AEDs responders) and 163 healthy controls. One step real time polymerase chain reaction (PCR) was used for the molecular analysis. Student\u2019s t-test, and Monto Carlo, chi-square and Mann\u2013Whitney tests were used for the statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All study participants were matched as regards the age, sex and body weight (<jats:italic>p<\/jats:italic>\u2009=\u20090.07, 0.347 and 0.462, respectively). They had the (AA) and (AG) genotypes but not the (GG) variant. No significant differences were found between cases and controls regarding (AG) and (AA) genotypes and A- and G-alleles (<jats:italic>p<\/jats:italic>\u2009=\u20090.09 and 0.3, respectively). We did not find significant differences between AEDs responders and resistant cases regarding the studied genotypes and alleles (<jats:italic>p<\/jats:italic>\u2009=\u20090.61 and 0.746, respectively). In the resistant group, we observed significant associations between the (AG) genotype and seizure frequency (<jats:italic>p<\/jats:italic>\u2009=\u20090.05), the tonic-clonic seizure (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), the younger age of first seizure attack (<jats:italic>p<\/jats:italic>\u2009=\u20090.03), abnormal electroencephalogram (EEG) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), the positive family history of epilepsy (<jats:italic>p<\/jats:italic>\u2009=\u20090.006), topiramate (<jats:italic>p<\/jats:italic>\u2009=\u20090.03) and valproic acid (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), while the (AA) genotype was associated with carbamazepine (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). While in AEDs responders, there were significant associations between the AG genotype and the abnormal EEG activity, levetiracetam and carbamazepine (<jats:italic>p<\/jats:italic>\u00a0=\u20090.016, 0.028 and 0.02).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The <jats:italic>SCN1A-A3184G<\/jats:italic> genotypes and alleles were not associated with the epilepsy risk among Egyptian children. Significant associations were reported between the AG genotype and some predictors of refractory epilepsy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-022-01350-2","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T06:03:21Z","timestamp":1662098601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Polymorphisms of the sodium voltage-gated channel, alpha subunit 1 (SCN1A -A3184G) gene among children with non-lesional epilepsy: a case-control study"],"prefix":"10.1186","volume":"48","author":[{"given":"Esraa","family":"Ghazala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa A.","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7479-7866","authenticated-orcid":false,"given":"Yahya","family":"Wahba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"issue":"3","key":"1350_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1055\/s-0035-1552922","volume":"35","author":"I Helbig","year":"2015","unstructured":"Helbig I. Genetic causes of generalized epilepsies. Semin Neurol. 2015;35(3):288\u201392.","journal-title":"Semin Neurol"},{"issue":"5","key":"1350_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrneurol.2014.62","volume":"10","author":"RH Thomas","year":"2014","unstructured":"Thomas RH, Berkovic SF. The hidden genetics of epilepsy\u2014a clinically important new paradigm. Nat Rev Neurol. 2014;10(5):283\u201392.","journal-title":"Nat Rev Neurol"},{"key":"1350_CR3","volume-title":"Ion channels of excitable membranes","author":"B Hille","year":"2001","unstructured":"Hille B. Ion channels of excitable membranes. 3rd ed. Sinauer: Sunderland; 2001.","edition":"3"},{"issue":"Pt 3","key":"1350_CR4","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/brain\/awm002","volume":"130","author":"LA Harkin","year":"2007","unstructured":"Harkin LA, McMahon JM, Iona X, Dibbens L, Pelekanos JT, Zuberi SM, et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain. 2007;130(Pt 3):843\u201352.","journal-title":"Brain."},{"key":"1350_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.seizure.2016.05.008","volume":"39","author":"S Usluer","year":"2016","unstructured":"Usluer S, Salar S, Arslan M, Yi\u015f U, Kara B, Tekt\u00fcrk P, et al. SCN1A gene sequencing in 46 Turkish epilepsy patients disclosed 12 novel mutations. Seizure. 2016;39:34\u201343.","journal-title":"Seizure."},{"issue":"6","key":"1350_CR6","doi-asserted-by":"publisher","first-page":"a022814","DOI":"10.1101\/cshperspect.a022814","volume":"6","author":"DI Kaplan","year":"2016","unstructured":"Kaplan DI, Isom LL, Petrou S. Role of sodium channels in epilepsy. Cold Spring Harb Perspect Med. 2016;6(6):a022814.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1350_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.seizure.2017.07.007","volume":"51","author":"S Bertok","year":"2017","unstructured":"Bertok S, Dol\u017ean V, Gori\u010dar K, Podkraj\u0161ek KT, Battelino T, Rener-Primec Z. The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy. Seizure. 2017;51:9\u201313.","journal-title":"Seizure."},{"issue":"6","key":"1350_CR8","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.neuron.2010.08.021","volume":"67","author":"WA Catterall","year":"2010","unstructured":"Catterall WA. Ion channel voltage sensors: structure, function, and pathophysiology. Neuron. 2010;67(6):915\u201328.","journal-title":"Neuron."},{"issue":"1","key":"1350_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13052-021-01027-2","volume":"47","author":"R Falsaperla","year":"2021","unstructured":"Falsaperla R, Scalia B, Giugno A, Pavone P, Motta M, Caccamo M, et al. Treating the symptom or treating the disease in neonatal seizures: a systematic review of the literature. Ital J Pediatr. 2021;47(1):85.","journal-title":"Ital J Pediatr"},{"key":"1350_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.seizure.2016.07.005","volume":"41","author":"WM Abo El Fotoh","year":"2016","unstructured":"Abo El Fotoh WM, Abd El Naby SA, Habib MS, ALrefai AA, Kasemy ZA. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children. Seizure. 2016;41:75\u201380.","journal-title":"Seizure."},{"issue":"5","key":"1350_CR11","first-page":"433","volume":"39","author":"P Wang","year":"2014","unstructured":"Wang P, Zhou Q, Sheng Y, Tang B, Liu Z, Zhou B. Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014;39(5):433\u201341.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"2","key":"1350_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1365-2125.2009.03437.x","volume":"68","author":"R Lakhan","year":"2009","unstructured":"Lakhan R, Kumari R, Misra UK, Kalita J, Pradhan S, Mittal B. Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population. Br J Clin Pharmacol. 2009;68(2):214\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1350_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.arcmed.2010.04.007","volume":"41","author":"A Ebrahimi","year":"2010","unstructured":"Ebrahimi A, Houshmand M, Tonekaboni SH, Fallah Mahboob Passand MS, Zainali S, Moghadasi M. Two novel mutations in SCN1A gene in Iranian patients with epilepsy. Arch Med Res. 2010;41(3):207\u201314.","journal-title":"Arch Med Res"},{"issue":"1","key":"1350_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0920-1211(03)00043-3","volume":"54","author":"IC Chou","year":"2003","unstructured":"Chou IC, Peng CT, Tsai FJ, Huang CC, Shi YR, Tsai CH. The lack of association between febrile convulsions and polymorphisms in SCN1A. Epilepsy Res. 2003;54(1):53\u20137.","journal-title":"Epilepsy Res"},{"issue":"5","key":"1350_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00439-013-1405-1","volume":"133","author":"L Baum","year":"2014","unstructured":"Baum L, Haerian BS, Ng HK, Wong VC, Ng PW, Lui CH, et al. Case\u2013control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy. Hum Genet. 2014;133(5):651\u20139.","journal-title":"Hum Genet"},{"issue":"11","key":"1350_CR16","doi-asserted-by":"publisher","first-page":"e0142408","DOI":"10.1371\/journal.pone.0142408","volume":"10","author":"A Daci","year":"2015","unstructured":"Daci A, Beretta G, Vllasaliu D, Shala A, Govori V, Norata GD, et al. Polymorphic variants of SCN1A and EPHX1 influence plasma carbamazepine concentration, metabolism and pharmacoresistance in a population of Kosovar Albanian epileptic patients. PLoS One. 2015;10(11):e0142408.","journal-title":"PLoS One"},{"issue":"15","key":"1350_CR17","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1073\/pnas.0407346102","volume":"102","author":"SK Tate","year":"2005","unstructured":"Tate SK, Depondt C, Sisodiya SM, Cavalleri GL, Schorge S, Soranzo N, et al. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc Natl Acad Sci U S A. 2005;102(15):5507\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1350_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1086\/516650","volume":"80","author":"EL Heinzen","year":"2007","unstructured":"Heinzen EL, Yoon W, Tate SK, Sen A, Wood NW, Sisodiya SM, et al. Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A. Am J Hum Genet. 2007;80(5):876\u201383.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1350_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/epi.13670","volume":"58","author":"RS Fisher","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522\u201330.","journal-title":"Epilepsia."},{"issue":"6","key":"1350_CR20","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s13760-020-01442-y","volume":"121","author":"S Eltalal","year":"2021","unstructured":"Eltalal S, El Ayouty M, El-Said A, Wahba Y. CYP2C9 (*2&*3) and CYP2C19 (*2&*3) polymorphisms among children with nonlesional epilepsy: a single-center study. Acta Neurol Belg. 2021;121(6):1623\u201331.","journal-title":"Acta Neurol Belg"},{"issue":"15","key":"1350_CR21","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1056\/NEJMoa021986","volume":"348","author":"A Siddiqui","year":"2003","unstructured":"Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med. 2003;348(15):1442\u20138.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"1350_CR22","first-page":"32","volume":"17","author":"R Kumari","year":"2011","unstructured":"Kumari R, Lakhan R, Garg R, Kalita J, Misra U, Mittal B. Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population. Indian J Hum Genet. 2011;17(Suppl 1):32\u201340.","journal-title":"Indian J Hum Genet"},{"issue":"1","key":"1350_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1124\/pr.117.014456","volume":"70","author":"J Oyrer","year":"2018","unstructured":"Oyrer J, Maljevic S, Scheffer IE, Berkovic SF, Petrou S, Reid CA. Ion channels in genetic epilepsy: from genes and mechanisms to disease-targeted therapies. Pharmacol Rev. 2018;70(1):142\u201373.","journal-title":"Pharmacol Rev"},{"key":"1350_CR24","doi-asserted-by":"publisher","first-page":"146585","DOI":"10.1016\/j.gene.2022.146585","volume":"832","author":"AM Elsaid","year":"2022","unstructured":"Elsaid AM, Zahran RF, Elmetwaly SM, Wahba Y, Megahed H, Elshazli RM. The potential impact of CYP2D6 (*2\/*4\/*10) gene variants among Egyptian epileptic children: a preliminary study. Gene. 2022;832:146585.","journal-title":"Gene."},{"issue":"4","key":"1350_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/pr.57.4.4","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev. 2005;57(4):397\u2013409.","journal-title":"Pharmacol Rev"},{"issue":"11","key":"1350_CR26","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/j.1528-1167.2012.03631.x","volume":"53","author":"M Oliva","year":"2012","unstructured":"Oliva M, Berkovic SF, Petrou S. Sodium channels and the neurobiology of epilepsy. Epilepsia. 2012;53(11):1849\u201359.","journal-title":"Epilepsia."},{"key":"1350_CR27","first-page":"49","volume":"16","author":"JW Kang","year":"2012","unstructured":"Kang JW, Kim DW, Lee YS, Lee YH, Lee KS. Polymorphism of SCN1A and SCN2A gene in pediatric refractory epilepsy patients. J Korean Epilepsy Soc. 2012;16:49\u201355.","journal-title":"J Korean Epilepsy Soc"},{"issue":"4","key":"1350_CR28","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1086\/319524","volume":"68","author":"A Escayg","year":"2001","unstructured":"Escayg A, Heils A, MacDonald BT, Haug K, Sander T, Meisler MH. A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus\u2014and prevalence of variants in patients with epilepsy. Am J Hum Genet. 2001;68(4):866\u201373.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1350_CR29","doi-asserted-by":"publisher","first-page":"e59383","DOI":"10.5812\/archneurosci.59383","volume":"5","author":"M Hosseini","year":"2018","unstructured":"Hosseini M, Ebrahimi A, Houshmand M, Zainali S, Tonekaboni SH, Moghaddasi M. SCN1A and ABCB1 polymorphisms in epilepsy. Arch Neurosci. 2018;5(1):e59383.","journal-title":"Arch Neurosci"},{"issue":"11","key":"1350_CR30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/FPC.0b013e3283117d67","volume":"18","author":"P Kwan","year":"2008","unstructured":"Kwan P, Poon WS, Ng HK, Kang DE, Wong V, Ng PW, et al. Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression. Pharmacogenet Genomics. 2008;18(11):989\u201398.","journal-title":"Pharmacogenet Genomics"},{"key":"1350_CR31","doi-asserted-by":"publisher","first-page":"591828","DOI":"10.3389\/fneur.2020.591828","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Zhong R, Lu Y, Zhao Q, Li G, Lin W. Association between SCN1A rs2298771, SCN1A rs10188577, SCN2A rs17183814, and SCN2A rs2304016 polymorphisms and responsiveness to antiepileptic drugs: a meta-analysis. Front Neurol. 2020;11:591828.","journal-title":"Front Neurol"},{"issue":"10","key":"1350_CR32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.seizure.2011.07.010","volume":"20","author":"M Tripathi","year":"2011","unstructured":"Tripathi M, Padhy UP, Vibha D, Bhatia R, Padma Srivastava MV, Singh MB, et al. Predictors of refractory epilepsy in North India: a case\u2013control study. Seizure. 2011;20(10):779\u201383.","journal-title":"Seizure."},{"issue":"10","key":"1350_CR33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.neurol.2015.06.004","volume":"171","author":"S Fray","year":"2015","unstructured":"Fray S, Kchaou M, Chebbi S, Belal S. Predictors factors of refractory epilepsy in childhood. Rev Neurol (Paris). 2015;171(10):730\u20135.","journal-title":"Rev Neurol (Paris)"},{"key":"1350_CR34","doi-asserted-by":"publisher","first-page":"107970","DOI":"10.1016\/j.neuropharm.2020.107970","volume":"172","author":"I Helbig","year":"2020","unstructured":"Helbig I, Ellis CA. Personalized medicine in genetic epilepsies\u2013possibilities, challenges, and new frontiers. Neuropharmacology. 2020;172:107970.","journal-title":"Neuropharmacology."},{"issue":"1","key":"1350_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/jpn.JPN_172_16","volume":"12","author":"R Falsaperla","year":"2017","unstructured":"Falsaperla R, Vitaliti G, Mauceri L, Romano C, Pavone P, Motamed-Gorji N, et al. Levetiracetam in neonatal seizures as first-line treatment: a prospective study. J Pediatr Neurosci. 2017;12(1):24\u20138.","journal-title":"J Pediatr Neurosci"},{"key":"1350_CR36","doi-asserted-by":"publisher","first-page":"106627","DOI":"10.1016\/j.eplepsyres.2021.106627","volume":"176","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liu J, Ye J. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: a meta-analysis. Epilepsy Res. 2021;176:106627.","journal-title":"Epilepsy Res"},{"key":"1350_CR37","doi-asserted-by":"publisher","first-page":"106615","DOI":"10.1016\/j.eplepsyres.2021.106615","volume":"173","author":"GX Zhao","year":"2021","unstructured":"Zhao GX, Zhang Z, Cai WK, Shen ML, Wang P, He GH. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis. Epilepsy Res. 2021;173:106615.","journal-title":"Epilepsy Res"},{"issue":"5","key":"1350_CR38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00228-019-02633-0","volume":"75","author":"L Shi","year":"2019","unstructured":"Shi L, Zhu M, Li H, Wen Z, Chen X, Luo J, et al. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients. Eur J Clin Pharmacol. 2019;75(5):655\u201363.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01350-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-022-01350-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01350-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T06:04:11Z","timestamp":1662098651000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-022-01350-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1186\/s13052-022-01350-2","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki, and approved by the Institutional Research Board of Mansoura University Faculty of Medicine, Mansoura, Egypt (Code No: MS.20.02.1041). Written informed consent was obtained from parents and\/or legal guardians of the study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}